home / stock / rtsl / rtsl news


RTSL News and Press, Rapid Therapeutic Science Laboratories Inc From 06/02/21

Stock Information

Company Name: Rapid Therapeutic Science Laboratories Inc
Stock Symbol: RTSL
Market: OTC
Website: rtslco.com

Menu

RTSL RTSL Quote RTSL Short RTSL News RTSL Articles RTSL Message Board
Get RTSL Alerts

News, Short Squeeze, Breakout and More Instantly...

RTSL - Rapid Therapeutic Prepares to file Investigational New Drug Application for its CBD Metered Dose Inhaler with FDA

DALLAS, June 02, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced today it has executed two (2) contracts to c...

RTSL - Cannabis Isolates Cross Over to Pharmaceutical-Grade Products Are More Prevalent Than Ever

Palm Beach, FL – January 26, 2021 – In the recent years the use of CBD products have grown exponentially. They have become an everyday item in most people’ lives. In drug and food stores, you see CBD infused items next to the candy section and infused ‘gummy bear...

RTSL - Rapid Therapeutic Hires Pharmaceutical Industry Authority to Oversee Labs

DALLAS, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on employing Metered Dose Inhaler (MDI) technology to deliver non-psychoactive cannabinoid compounds, announc...

RTSL - Global Market for Cannabinoid-Based Pharmaceuticals Expected to Reach $50 Billion by 2029

Palm Beach, FL – December 3, 2020 – The medical segment of the cannabis explosion over the last decade, has not always been in the forefront… but its day is coming. The revenues from cannabinoid-based pharmaceuticals is projected to rise over the next several years. Can...

RTSL - Rapid Therapeutic Selects Clinical Research Center to Start Clinical Trials Using its Proprietary CBD and CBG Formulation

DALLAS, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver cannabinoid compounds, su...

RTSL - CBD Isolates Expected to Gain Lion Share of Cannabis Market

Palm Beach, FL – December 1, 2020 – CBD products are wildly popular and widely marketed, but each CBD product is not the same… yes, each has CBD in it but what type of CBD is in there? Most of these products are often not just CBD. Rather, they are full or broad-spe...

RTSL - Rapid Therapeutic Completes $14 Million Acquisition of Razor Jacket

DALLAS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver cannabinoid compounds, su...

RTSL - Regulatory Landscape for CBD Medical Grade Products Targeting New Safety Levels for Consumers

Palm Beach, FL – September 30, 2020 – Medical grade CBD products market is poised for significant increase in revenues for the next several years. It seems that every new industry report has higher projections that the earlier reports. Data Bridge Markets Research itself has p...

RTSL - Rapid Therapeutic to buy out all assets of Razor Jacket

Rapid Therapeutic Science Laboratories (RTSL) has signed a letter of intent ((LOI)) to acquire all of the assets of Razor Jacket, LLC based in Hillsboro, Oregon in a cash and stock transaction. Razor Jacket currently supplies medical grade CBD and CBG Isolate to RTSL. These isolates are the a...

RTSL - Rapid Therapeutic Enters Letter of Intent to Expand Production Capability to 3,000,000 MDI and $100,000,000 in Revenue Annually

DALLAS, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver cannabinoid compounds, s...

Previous 10 Next 10